BAK1 and Myocardial fibrosis: The present study revealed that in the setting of diabetic cardiomyopathy, BAK reversed the adverse effects of hyperglycemia-induced oxidative stress in diabetic hearts, as demonstrated by improvement of cardiac function, mitigation of pathological cardiac hypertrophy, prevention of myocardial fibrosis, and elevation of cardiomyocyte survival rate.